Search research articles
Contact Us
Filters
Showing results (411-420 of 629) with videos related to
Page
of 63
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug
|
February 1, 2023
The Association Between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study
Jacob P Thyssen, Lea K Nymand, Julia-Tatjana Maul, et al.
The Journal of Allergy and Clinical Immunology
|
January 8, 2011
TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis
Maya Zimmermann, Andrea Koreck, Norbert Meyer, et al.
BJU International
|
November 22, 2017
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir
Dominik Abt, Andrej Besse, Lenka Sedlarikova, et al.
Hepatology (Baltimore, Md.)
|
August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling
Jeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
The Journal of Dermatological Treatment
|
February 12, 2016
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
Astrid Sönnichsen, Ieva Saulite, Johanna Mangana, et al.
Future Oncology (London, England)
|
April 1, 2020
TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer
Hope S Rugo, Aditya Bardia, Sara M Tolaney, et al.
Cancer Research
|
March 16, 2011
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer
Nelofer Syed, Helen M Coley, Jalid Sehouli, et al.
Cancer Immunology, Immunotherapy : CII
|
April 14, 2006
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men, Edith Uetz-von Allmen, Markus Fopp, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2025
PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [<sup>68</sup>Ga]Ga-PSMA-11, [<sup>68</sup>Ga]Ga-PSMA I&T, and [<sup>18</sup>F]PSMA-1007
Caroline Burgard, Madita Frei, Arne Blickle, et al.
Clinical Chemistry
|
June 18, 2005
Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice
György Sölétormos, Axel Semjonow, Paul E C Sibley, et al.
Page
of 63
Search research articles
Search
Showing results (411-420 of 629) with videos related to
Sort By:
Page
of 63
Dermatitis : Contact, Atopic, Occupational, Drug
|
February 1, 2023
The Association Between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study
Jacob P Thyssen, Lea K Nymand, Julia-Tatjana Maul, et al.
The Journal of Allergy and Clinical Immunology
|
January 8, 2011
TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis
Maya Zimmermann, Andrea Koreck, Norbert Meyer, et al.
BJU International
|
November 22, 2017
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir
Dominik Abt, Andrej Besse, Lenka Sedlarikova, et al.
Hepatology (Baltimore, Md.)
|
August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling
Jeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
The Journal of Dermatological Treatment
|
February 12, 2016
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
Astrid Sönnichsen, Ieva Saulite, Johanna Mangana, et al.
Future Oncology (London, England)
|
April 1, 2020
TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer
Hope S Rugo, Aditya Bardia, Sara M Tolaney, et al.
Cancer Research
|
March 16, 2011
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer
Nelofer Syed, Helen M Coley, Jalid Sehouli, et al.
Cancer Immunology, Immunotherapy : CII
|
April 14, 2006
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men, Edith Uetz-von Allmen, Markus Fopp, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2025
PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [<sup>68</sup>Ga]Ga-PSMA-11, [<sup>68</sup>Ga]Ga-PSMA I&T, and [<sup>18</sup>F]PSMA-1007
Caroline Burgard, Madita Frei, Arne Blickle, et al.
Clinical Chemistry
|
June 18, 2005
Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice
György Sölétormos, Axel Semjonow, Paul E C Sibley, et al.
Page
of 63